Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of ...

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

At present, North America dominates the global gastrointestinal agents market. Particularly U.S. captures the largest market share in the regional gastrointestinal agents market. However, the region ...

A new report from the Agency for Healthcare Research and Quality and the Medical Expenditure Panel Survey has shown that the number of Americans purchasing at least one outpatient prescription ...

Company also made a $0.5 million investment for rights in multiple indications and regions. Salix Pharmaceuticals is paying Napo Pharmaceuticals $4.5 million in cash upfront for rights to crofelemer ...

A new study published in the American College of Rheumatology journal Arthritis & Rheumatism reveals that not prescribing gastroprotective agents for patients taking COX-2 inhibitors increases the ...

Virtus announced a voluntary recall of 7 lots of Hyoscyamine Sulfate 0.125mg due to both superpotent and subpotent test results. Hyoscyamine sulfate is an anticholinergic agent used as adjunctive ...

June 7 -- FRIDAY, June 6 (HealthDay News) -- Whole milk does as good a job as a diluted barium solution when used as an oral contrast agent in patients getting a gastrointestinal CT scan, and it is ...